NCT03224793View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

June 12, 2018

Study Completion Date

June 12, 2018

Conditions
Healthy Subjects
Interventions
DRUG

BIIB059

Administered as specified in the treatment arm

DRUG

Placebo

Administered as specified in the treatment arm

Trial Locations (1)

90630

West Coast Clinical Trials, Cypress

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY